ArticleInternational journal of hematology2025

Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan.

Nami Tagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.